Contact
Dispensary Authority covers cannabis dispensary regulations, licensing frameworks, compliance standards, and patient access rights across all U.S. jurisdictions where cannabis programs operate. This contact page explains the scope of inquiries the site addresses, what information helps produce a useful response, and what realistic timelines look like. Dispensary law touches federal scheduling under the Controlled Substances Act (21 U.S.C. § 801 et seq.), state-level licensing codes, and local zoning ordinances simultaneously — so the more specific an inquiry, the more grounded the response can be.
Service area covered
The site operates at national scope, covering all 50 states and the District of Columbia. That includes the 38 states with active medical cannabis programs and the 24 states that have enacted adult-use legalization as of laws published through 2024 (NCSL State Medical Cannabis Laws). Content spans the full regulatory stack: state licensing agencies such as California's Department of Cannabis Control, Colorado's Marijuana Enforcement Division, and Florida's Office of Medical Marijuana Use; federal frameworks including DEA scheduling, IRS treatment under 26 U.S.C. § 280E, and FinCEN guidance on cannabis banking; and operational standards covering METRC seed-to-sale tracking, ISO/IEC 17025-accredited lab testing requirements, and state-mandated security protocols.
Inquiries that fall outside this scope include clinical medical advice, product recommendations for individual patients, legal representation, or real-time product availability at specific dispensaries. Those belong with licensed professionals — a physician, a licensed cannabis attorney, or a state-credentialed pharmacist.
What to include in your message
A precise question gets a precise answer. Vague messages tend to produce vague replies, which helps no one.
When reaching out, the following details meaningfully improve response quality:
- State or jurisdiction — Cannabis law is almost entirely state-administered. A licensing question in Oregon operates under entirely different rules than the same question in New York. Naming the state is the single most useful thing an inquirer can include.
- License type or business stage — The regulatory obligations for a cultivation facility differ substantially from those of a retail dispensary or a delivery-only operation. If the question involves a specific license class (e.g., a Type 10 retailer license in California or a MMTC license in Florida), include it.
- Regulatory agency or code reference — If the question stems from a specific statute, regulation, or agency notice, citing it directly — for example, referencing a provision in Michigan's Medical Marihuana Facilities Licensing Act, MCL 333.27101 — allows the most targeted response.
- Patient vs. operator context — Medical patient access questions (card requirements, purchase limits, reciprocity) follow a different research path than operator compliance questions (inventory tracking, advertising restrictions, tax treatment).
- Urgency context — Not deadline urgency, but context: a pre-application question, a renewal issue, or a general research inquiry each warrant different depth.
The comparison that matters most here: a message reading "I have a cannabis question in Colorado about delivery" will get a general overview; a message reading "Colorado Retail Marijuana Store licensee — question about Regulation 1 CCR 212-3 delivery vehicle requirements" gets a precise, sourced answer.
Response expectations
The site handles a research and editorial function, not a legal or medical helpline. Response timelines reflect that distinction. General content inquiries, factual corrections, and editorial feedback typically receive a reply within 3 to 5 business days. Regulatory research questions with sufficient specificity — meaning they include jurisdiction, license type, and a clear scope — receive structured responses within 5 to 7 business days.
Corrections and factual disputes receive priority handling. If a page on the site misattributes a statute, cites an outdated penalty ceiling, or mischaracterizes an agency's enforcement posture, that is the highest-value message the editorial team can receive. Include the specific page URL and the precise claim in question, alongside the correct source — ideally a direct link to the relevant state agency code or federal register entry.
The site does not provide legal opinions, clinical guidance, or individualized professional advice of any kind. Responses that would require the exercise of professional judgment reserved for licensed attorneys, physicians, or compliance consultants will be declined or redirected to appropriate resources such as the Marijuana Policy Project's state policy database or NORML's legal resources.
Additional contact options
For sourcing questions tied to specific regulatory frameworks, the following public agency portals are primary reference points and accept public inquiries directly:
- DEA Diversion Control Division — deadiversion.usdoj.gov — for federal scheduling and DEA registration matters
- FinCEN — fincen.gov — for cannabis banking guidance and BSA compliance questions
- IRS Small Business/Self-Employed Division — irs.gov — for § 280E tax treatment
- State cannabis control agencies — each state's licensing authority maintains a public inquiry portal; a provider network of all active state agencies is covered at Dispensary State-by-State Map
For patient-specific access questions — medical card eligibility, purchase limits by condition category, or interstate reciprocity provisions — the Medical Cannabis Patient Registration and Dispensary Reciprocity Laws pages address the most common scenarios in depth before a direct inquiry becomes necessary.
Editorial partnerships, syndication requests, and data licensing questions can be noted in the subject line of any message sent through the site's standard contact form. Those are reviewed on a rolling basis with no fixed turnaround commitment.
Report a Data Error or Correction
Found incorrect information, an outdated fact, or a broken link? Use the form below.
References
- 21 U.S.C. § 801 et seq.
- 26 U.S.C. § 280E
- deadiversion.usdoj.gov
- fincen.gov
- Marijuana Policy Project's state policy database
- NCSL State Medical Cannabis Laws